Background: Few data are available comparing cardiovascular disease (CVD) biomarker
profiles between women and men in the general population. We analyzed sex-based …

L-Homoarginine (hArg)((2S)-amino-6-Carbamimidamidohexanoic acid) is a non-essential
cationic amino acid that may be synthesised from the lysine catabolism or the …

Upcoming experimental and epidemiological data have identified the endogenous non‐
proteinogenic amino acid L‐homoarginine (L‐hArg) not only as a novel biomarker for …

Aims Low blood concentrations of the naturally occurring amino acid L‐homoarginine (L‐
hArg) are related to impaired cardiovascular outcome and mortality in humans and animals …

Low plasma concentration of L-homoarginine is an independent predictor of cardiovascular
events and total mortality. Experimental data indicate that supplementation of L …

Asymmetric dimethylarginine (ADMA) and l-homoarginine (hArg) are l-arginine (Arg)
metabolites derived from different pathways. Protein arginine N-methyltransferase (PRMT) …

Homoarginine is associated with cardio-and cerebrovascular morbidity and mortality.
However, the underlying pathomechanisms remain elusive. Here, we evaluated the …

Homoarginine is an endogenous amino acid whose levels are reduced in patients with
renal, cardio-and cerebrovascular disease. Moreover, low homoarginine concentrations …

Lower circulating homoarginine concentrations have been associated with morbidity and
mortality in patients with established cardiovascular disease (CVD). We assayed plasma …

Background Increasing evidence suggests that L‐homoarginine, an endogenous analogue
of the amino acid L‐arginine, may have beneficial effects on vascular homeostasis. We …